References
- Orentreich N., Brind J. L., Rizer R. L, Vogelman J. H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J. Clin. Endocrinol. Metab 1984; 59: 551–555
- Hennebold J. D., Daynes R. A. Regulation of macrophage dehydroepiandrosterone sulfate metabolism by inflammatory cytokines. Endocrinol 1994; 135: 67–75
- Padgett D. A., Loria R. M. In vitro potentiation of lymphocyte activation by dehydroepiandrosterone, androstenediol, and androstenetriol. J. Immunol 1994; 153: 1544–52
- Ridson G., Kumar V., Bennett M. Differential effects of dehydroepiandrosterone (DHEA) on murine lymphopoiesis and myelopoiesis. Exper. Hematol 1991; 19: 128–31
- Araneo B. A., Dowell T., Diegel M., Daynes R. A. Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5, and gamma-interferon, but not IL-2 by activated murine T cells. Blood 1991; 78: 688–99
- Gillis S., Crabtree G., Kendall A. Glucocorticoid-induced inhibition of T cell growth factor production. II. The effect of cell proliferation and interleukin-2 production. J. Immunol 1979; 123: 1632–1638
- Manfro R. C., Pohanka E., Tomlanovich S, Benet L. Z., Garovay M. R. Cyclosporin A and prednisolone. An additive inhibitory effect of cell proliferation and interleukin-2 production. Trans Proc 1989; 21: 1457–1459
- Wald J. A., Jusko W. J. Prednisolone pharmacodynamics: leukocyte trafficking in the rat. Life Sci. 1994; 55: 371–378
- Van R. F., Vollenhoven E. G., Engleman, McGuire J. L. An open study of dehydroepiandrosterone in systemic lupus erythematosus. Arthr. Rheum 1994; 37: 1305–10
- Abbas A., Lichman A., Pober J. Cellular and molecular immunology. W.B Saunders Press, Philadelphia 1994
- Chou T., Talalay P. Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul 1984; 22: 27–55
- Drewinko B., Loo T. L., Brown B., Gottlieb J. A, Freireich E. J. Combination chemotherapy in vitro with adriamycin. Observation of additive, antagonistic, and synergistic effects when used in two-drug combinations on cultured human lymphoma cells. Can. Biochem. Biophys 1976; 1: 187–195
- Carlström K., Brody S., Lunell N-O., Lagrelius A., Möllerström G., Pousette A., Rannevik G., Stege R., Von Schoultz B. Dehydroepiandrosterone sulfate and dehydroepiandrosterone in serum: differences related to age and sex. Maturitas 1988; 10: 297–306
- Greco W. R, Bravo G., Parsons J. C. The search for synergy: A critical review from a response surface perspective. Pharmacol. Reviews 1995; 47: 331–385
- Bettens F., Kristensen F, Walker C., Schwul'era U., Bonnard G. D. Lymphokine regulations of activated lymphocytes. II. Glucocorticoid and anti-Tac-induced inhibition of human T lymphocyte proliferation. J. immunol 1984; 132: 261–265
- Gillis S., Crabtree G., Smith K. Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation. J. Immunol 1979; 123: 1624–1631
- Scheinman R. I., Cogswell P. C., Lofquist A. K., Baldwin A. S. Role of transcriptional activation of IkBα in mediation of immunosuppression by glucocorticoids. Science 1995; 270: 283–286
- Siebenlist U., Franzoso G., Brown K. Structure, regulation and function of NF-kB. Annu. Rev. Cell Biol 1994; 10: 405–55
- Meikle A. W., Dorchuck R. W., Araneo B. A., Stringham J. D., Evans T. G., Spruance S. L., Daynes R. A. The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells. J. Ster. Biochem. Mol. Biol 1992; 42: 293–304